news
NEW YORK CITY and CHICAGO, Nov. 9, 2026– A first-of-its-kind analysis of the 52 leading biomedical research study organizations throughout 8 Midwest states reveals the area exceeds the country in medical trials, gene treatment, and patents, the abilities that turn clinical discoveries into brand-new treatments for clients. The Cure analysis, established in partnership with the Chicago Biomedical Consortium (CBC) and utilizing Cure Innovation Index information, likewise determines spaces the area need to near to turn more of its science into business and treatments. Remedy and the CBC will launch the complete report, “Built to Innovate: The Biomedical Power and Potential of a Connected Midwest,” on Thursday, Nov. 12, at the 2026 Midwest BioBuilders Summit in Chicago.
The Cure Innovation Index is the very first evidence-based procedure of how well the leading 303 U.S. research study organizations turn science into real-world effect. The brand-new report assesses universities, institutes, and centers in Illinois, Indiana, Kentucky, Michigan, Minnesota, Missouri, Ohio and Wisconsin.
Inside the Report
The report discovers the Midwest area is constructed to evaluate and make brand-new medications, however with spaces that no single organization can close alone. The complete findings, consisting of some unexpected outcomes about where the Midwest leads, where it lags, and which organizations are more powerful than their rankings recommend, will be launched at the Summit.
“When people talk about U.S. life sciences, the Midwest isn’t on the radar, but it should be,” stated Seema Kumar, Chief Executive Officer of Cure, the New York City-based health care development community, who will open the Summit. “Boston may be biotech’s darling and the Bay Area its birthplace, but the Midwest has standout strengths in the areas that get discoveries tested, proven and turned into new treatments for patients. There is so much untapped potential here, and collaboration across institutions, investors, and industry is what will unlock it.”
Michelle Hoffmann, PhD, Executive Director of the CBC, echoes Kumar and the report’s findings. “The Midwest has exceptional science. What we need is a stronger, more connected ecosystem that can turn that science into companies, partnerships, and ultimately therapies that reach patients,” stated Hoffmann. “I know here in Illinois, we have spent the last five years building infrastructure like Portal Innovations, the University of Chicago’s Hyde Park Labs, the University of Illinois’s Discovery Partners Institute, and Northwestern’s Querrey InQbation Labs. The opportunity now is to attract the capital and connect the expertise needed to scale that innovation. That’s why we created the Midwest BioBuilders Summit.”
Midwest’s flagship biotech event: 2026 Midwest BioBuilders Summit
The Summit, arranged by the CBC, will display more than 100 appealing biomedical developments and emerging business from throughout 7 Midwest states, representing 16 universities and research study organizations. The density of the Midwest’s development draws in equity capital financiers, pharmaceutical executives, scholastic innovators, biotech creators and environment leaders to advance the Midwest’s growing biomedical development economy.
The Summit, which intends to increase the presence of the Midwest’s early-stage biotech pipeline, will include a keynote address from Alexis Borisy, Co-Founder and Managing Partner of Curie.Bio; a fireside discussion with Martin Burke, MD, PhD, Co-Founder of Excelsior Sciences, and Mark Michalski, MD, Chief Information Officer at Deerfield Management, checking out AI-driven drug discovery; and conversations including leaders from Pfizer Ventures, Johnson & & Johnson Innovation, Takeda, and other leading companies. Pre-summit occasions consist of satellite programs concentrated on females’s health development and a market intro to quantum biology.
“The Midwest has long been a powerhouse of biomedical discovery, but our strengths and the potential of our innovation ecosystem do not get the attention they deserve or need,” Hoffmann stated. “The Cure Innovation Index’s evidence-based data shows what the CBC’s deep understanding of the region’s translational landscape has known: There is huge potential, but we need to do some work, especially in computing, industry relationships, and visibility.”
Interested celebrations can sign up for the Summit at: https://cbcbiobuildersummit2026.eventify.io/px/welcome
About the Chicago Biomedical Consortium
The Chicago Biomedical Consortium (CBC) is a not-for-profit company working to make the Midwest a leading source of biotech development. The CBC works throughout our network of 9 Illinois universities to assess and de-risk early-stage discoveries with market rigor: determining threats early, confirming outcomes separately, and advancing just the programs that make it. Our objective is to develop investable business with strong clinical and business structures and to establish the next generation of translational skill to support them. To find out more, see https://www.thegreenhousecbc.org/
About Cure
Remedy is the premier health care development environment that supplies understanding, facilities and tools to speed up development towards treatments. Headquartered in New York City, Cure assembles all essential stakeholders for development throughout its physical and digital neighborhood. The school homes flagship occasion places and is home to health care companies from concept phase to public business. Remedy members get to premium chances and curated connections. In 2026, the Cure Innovation Index was released, supplying unequaled exposure into how research study organizations equate advancement science into real-world health effect. Innovate with Cure at wewillcure.com
About the Cure Innovation Index
The Cure Innovation Index introduced in April 2026, assesses 25 signs throughout 3 core domains: Research Capabilities, Entrepreneurial Readiness and Market Translation. The Index ranks the leading 303 scholastic organizations, made up of 243 universities and 60 institutes and centers, from more than 6,000 across the country. It supplies peer-benchmarked contrasts and tailored enhancement suggestions. The multi-dimensional method of the Index utilizes confirmed information incorporated from more than a lots federal and business databases. These consist of the NSF Higher Education Research and Development (HERD) Survey and Dimensions, an inter-linked research study details system supplied by Digital Science.
/ Public Release. This product from the stemming organization/author(s) may be of the point-in-time nature, and modified for clearness, design and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions revealed herein are exclusively those of the author(s). View completely here.
Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND
Subscribe to get the latest posts sent to your email.
